APDA Awards More Than $1.7 Million to Parkinson’s Disease Researchers

APDA Awards More Than $1.7 Million to Parkinson’s Disease Researchers

Hoping to lure new researchers to the Parkinson’s disease field and to support others’ new and innovative ideas, the American Parkinson Disease Association (APDA) has awarded more than $1.7 million in fellowships, research grants, and funding for APDA Centers for Advanced Research.

 The awards include a highly competitive George C. Cotzias Fellowship, two post-doctoral fellowships, 11 research grants, and eight APDA Centers for Advanced Research. The centers support front-line research into the cause, treatment, and eventual cure of Parkinson’s, according to a press release.

Applications are reviewed annually by the APDA’s Scientific Advisory Board (SAB). During that meeting, board members also decide the kind of research they want to invest in that year.

Among other things, the association’s support this year will give insight into the disease’s new biomarkers, and examine how and why Parkinson’s affects genders and some ethnic groups differently, said Rebecca Gilbert, MD, PhD, APDA’s vice president and chief scientific officer.

“APDA is funding an exciting array of projects this year,” she said.

In the past, research projects have produced important pilot data, according to the release, resulting in lucrative research grants from the National Institutes of Health and other funding entities.

“It is vital to accelerate research and support translational ideas that can lead to new treatments for those people living with [Parkinson’s disease],” said David G. Standaert, MD, PhD, John N. Whitaker professor and chair of neurology at the University of Alabama at Birmingham‘s School of Medicine, and SAB chairman. “APDA’s SAB is focused on investing in the best science to support that important mission.”

This year’s George C. Cotzias Fellowship went to emerging physician-scientist Aasef Shaikh, PhD, of the Cleveland VA Medical Center and Case Western Reserve University. The three-year award is designed to fund a long-term Parkinson’s project.

Shaikh’s project is aimed at learning how Parkinson’s affects the part of the brain that maintains gait and balance.

Learn more about the awardees and browse all APDA-funded research here. Researchers and physicians interested in applying for APDA funding can visit here for 2019-2020 opportunities.

APDA’s Centers for Advanced Research fund expansive Parkinson’s research programs. These programs include novice researchers, fellowship and early-stage discovery programs, and advanced clinical translation. Through a rigorous application process, two new centers were chosen this year.

 “The work being done as a result of the grants in this new funding cycle will have an incredible impact on the world of [Parkinson’s disease],” said Leslie A. Chambers, APDA’s president and CEO.

In its 57-year history, APDA has raised more than $177 million to provide patient services, increase public awareness of Parkinson’s, support its research, and ultimately end the disease.

2 comments

  1. Maureen Stewart says:

    I was diagnosed 2 years ago at age 63. Symptoms were tremor in right leg, loss of handwriting ability, and soft voice. I also have difficulty rising from a seated position and have balance issues. I started out taking only Azilect, then Mirapex, and 6 months ago Sinemet. Several months ago I started falling frequently, hence the reason for Sinemet. I tried every shots available but nothing worked. In June 2018, my neurologist and I decided to go with natural treatment and was introduced to Natural Herbal Gardens natural organic Parkinson’s Herbal formula, i had a total decline of symptoms with this treatment, the Tremor, falling frequently, stiffness, body weakness, balance issues, depression and others has subsided. Visit Natural Herbal Gardens official website ww w. naturalherbalgardens. com. This treatment is a breakthrough for all suffering from Parkinson’s, don’t give up Hope. Keep Sharing the Awareness, herbs are truly gift from God.

Leave a Comment

Your email address will not be published. Required fields are marked *